Play

When large populations of people were screened for multiple cancers using a blood test, not only didn’t cancers get found earlier, others who were not screened had delays in their diagnosis and treatment of cancer. Johns Hopkins Kimmel Cancer Center …

Should blood tests to screen for cancer be used on a population basis? Elizabeth Tracey reports Read more »

Play

For some types of cancer obesity is clearly a risk factor. Now a new study shows that when people with obesity take a GLP-1 agonist to lose weight, they also reduce their risk for these cancers. Kimmel Cancer Center director …

How do GLP-1 agonists compare against other strategies for weight reduction and cancer risk reduction? Elizabeth Tracey reports Read more »

Play

GLP-1 agonists are a class of drugs originally developed to treat diabetes but have been shown to be helpful for weight loss. Now a new study looks at whether their use reduces the risk of obesity related cancers. William Nelson, …

How are one class of diabetes drugs related to cancer risk? Elizabeth Tracey reports Read more »

Play

In this episode of the CNI podcast, we sit down with a senior quality improvement team leader to explore her career journey, what it looks like to lead improvement work across a health system, and a real-world example of how …

Episode 84: Quality Improvement Spotlight – Kelly Forbes | Johns Hopkins Center for Nursing Inquiry Read more »